to - 医索

找到约 1557 条结果

Global Retrospective Study Comparing Consolidation ALK TKl to Durvalumab or Observation after Chemoradiation in Unresectable Locally Advanced ALK NSCLC

医客学院 - 会议报告集

ETOP 13-18 BEAT-meso

医客学院 - 会议报告集

Efficacy and Safety of Erdafitinib in Adults WithNSCLC and Prespecified Fibroblast Growth FactorReceptor Alterations in the Phase 2 Open-labelSingle-arm RAGNAR Trial

医客学院 - 会议报告集

Adjuvant icotinib of 12 months or 6 months versus observationfollowing adjuvant chemotherapy for resected EGFR-mutatedstage ll-lllA non-small-cell lung cancer (ICTAN, GASTO1002) arandomized phase 3 trial

医客学院 - 会议报告集

Total neoadjuvant treatment with long-course radiotherapyversus concurrent chemoradiotherapy in local advanced rectalcancer with high risk factors (TNTCRT)A multicenter,randomized, open-label, phase

医客学院 - 会议报告集

Three-year disease-free survival after transanal vsaparoscopic total mesorectal excision for rectalcancer (TaLaR)A randomized clinical trial

医客学院 - 会议报告集

Phase l trial of hypoxia-responsive CEA CAR-T celltherapy in patients with heavily pretreated solid tumorvia intraperitoneal or intravenous transfusion

医客学院 - 会议报告集

Overall survival (oS) of phase 3 CodeBreak 300 study ofsotorasib plus panitumumab (soto pani) versus investigator'schoice of therapy for KRAS G12c-mutated metastatic colorectacancer (mCRc)

医客学院 - 会议报告集

Neoadiuvant Pembrolizumab stratified to tumourmutation burden for High-Risk Stage 2 or Stage 3deficient-MMRMSl-High Colorectal CancerThe multicentre Phase 2 NEOPRISM-CRC trial

医客学院 - 会议报告集

Durable complete responses to PD-1 blockadealone in dMMR locally advanced rectal cancer

医客学院 - 会议报告集

今日实时热搜